Antibiotics Improve the Treatment Efficacy of Oxaliplatin-Based but Not Irinotecan-Based Therapy in Advanced Colorectal Cancer Patients.

Hiroo ImaiKen SaijoKeigo KomineYuya YoshidaKeiju SasakiAsako SuzukiKota OuchiMasahiro TakahashiShin TakahashiHidekazu ShirotaMasanobu TakahashiChikashi Ishioka

Published in: Journal of oncology (2020)

To improve the treatment efficacy of oxaliplatin-based therapy in advanced CRC patients, adding antibiotics is a potential therapeutic option.

Keyphrases

end stage renal disease
newly diagnosed
combination therapy
replacement therapy
bone marrow